Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care    FME   DE0005785802

FRESENIUS MEDICAL CARE (FME)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
08/14/2018 08/15/2018 08/16/2018 08/17/2018 08/20/2018 Date
84.56(c) 84.04(c) 84.92(c) 85.02(c) 85.5(c) Last
497 280 629 243 424 338 391 337 466 911 Volume
+0.57% -0.61% +1.05% +0.12% +0.56% Change
More quotes
Financials (EUR)
Sales 2018 17 044 M
EBIT 2018 2 639 M
Net income 2018 1 649 M
Debt 2018 5 553 M
Yield 2018 1,41%
Sales 2019 18 101 M
EBIT 2019 2 654 M
Net income 2019 1 448 M
Debt 2019 5 145 M
Yield 2019 1,44%
P/E ratio 2018 16,73
P/E ratio 2019 18,22
EV / Sales2018 1,86x
EV / Sales2019 1,73x
Capitalization 26 205 M
More Financials
Company
Fresenius Medical Care AG & Co. KGaA provides products and services for patients with chronic kidney failure.The company's products include dialysis machines, dialyzers and related disposables.It also offers renal information technology solutions and provides services such as renal replacement... 
More about the company
Surperformance© ratings of Fresenius Medical Care
Trading Rating : Investor Rating :
More Ratings
Latest news on FRESENIUS MEDICAL CARE
08/16FRESENIUS MEDICAL CARE : Patent Application Titled "Luer Lock Tools And Methods ..
AQ
08/15FRESENIUS MEDICAL CARE : $168,000 Federal Contract Awarded to Fresenius USA
AQ
08/10FRESENIUS MEDICAL CARE AG & CO. KGAA : Notification and public disclosure of tra..
EQ
08/09FRESENIUS MEDICAL CARE : Frenova Renal Research Adds Fifth Practice to its Site ..
AQ
08/09FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 40, Section ..
EQ
08/09FRESENIUS MEDICAL CARE : Patent Issued for Disposable Apparatus And Kit For Cond..
AQ
08/07FRESENIUS MEDICAL CARE : continues to grow in the second quarter and confirms ou..
AQ
08/07FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 40, Section ..
EQ
08/02FRESENIUS MEDICAL CARE : Amgen's Parsabiv Doubles in Most Recent Quarter But Str..
AQ
08/02FRESENIUS MEDICAL CARE : achieves preclinical milestone in its regenerative medi..
AQ
More news
Sector news : Healthcare Facilities & Services - NEC
08/06Lower NHS referrals dent Spire Healthcare's profit view, shares sink
RE
07/31Fresenius SE Reports Higher 2Q Net Profit, Backs 2018 Outlook
DJ
07/26Wall St. rises as Trump touts EU trade concessions
RE
07/25HCA HOSPITAL AMERICA : Healtre Raises Guidance, Beats 2Q Estimates -- Earnings R..
DJ
07/13Fresenius SE Had Testing Issues Like Akorn's, Executive Says -Bloomberg
DJ
More sector news : Healthcare Facilities & Services - NEC
MarketScreener Strategies on FRESENIUS MEDICAL CARE 
FRESENIUS MEDICAL CARE - 05/14
The technical configuration is positive
BUY
FRESENIUS MEDICAL CARE - 04/10
No turn-around in sight
BUY
More Strategies
Latest Tweets
08/19FRESENIUS SE &/S $FSNUY versus OraSure Technologies $OSUR Head-To-Head Su.. 
08/18Fresenius Medical Care AG & Co.’s $FMS Neutral Rating Reaffirmed at Royal.. 
08/18Contrasting FRESENIUS SE &/S $FSNUY & Interpace Diagnostics Group $ID.. 
08/17Analyzing Cerus $CERS and FRESENIUS SE &/S $FSNUY  
08/17TREND REVERSAL UP ALERT: $FMS FRESENIUS MEDICAL CARE AG ? TradeIdeas via  
More tweets
Qtime:87
News from SeekingAlpha
08/07DIVIDEND PORTFOLIO REVIEW : Busy Earnings Season, Heavy Buying, Growing Dividend.. 
08/01Meet The 'Safer' 35 Healthcare High Yield WallStars For July 
08/01Wall Street Favorite Healthcare Equities For July Topped By CVS Health 
07/31Fresenius Medical Care AG & Co. KGaA's (FMS) CEO Rice Powell on Q2 2018 Resul.. 
07/31Fresenius Medical Care AG & Co. KGAA 2018 Q2 - Results - Earnings Call Slides 
Chart FRESENIUS MEDICAL CARE
Duration : Period :
Fresenius Medical Care Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 93,6 €
Spread / Average Target 10%
EPS Revisions
Managers
NameTitle
Rice Powell Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Michael Brosnan Chief Financial Officer
Olaf Schermeier CEO-Global Research & Development
Dieter Schenk Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS MEDICAL CARE-3.14%29 970
HCA HOLDINGS (HOSPITAL CORPORATION AMERICA)49.66%45 529
LABORATORY CORPORATION OF AMERICA HOLDINGS14.22%18 565
QUEST DIAGNOSTICS13.15%15 230
DAVITA0.33%12 099
UNIVERSAL HEALTH SERVICES12.75%11 929